|
1
|
Khwaja A, Bjorkholm M, Gale RE, Levine RL,
Jordan CT, Ehninger G, Bloomfield CD, Estey E, Burnett A,
Cornelissen JJ, et al: Acute myeloid leukaemia. Nat Rev Dis
Primers. 2(16010)2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pelcovits A and Niroula R: Acute myeloid
leukemia: A review. R I Med J. 103:38–40. 2020.PubMed/NCBI
|
|
3
|
De Kouchkovsky I and Abdul-Hay M: ‘Acute
myeloid leukemia: A comprehensive review and 2016 update’. Blood
Cancer J. 6(e441)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lonetti A, Pession A and Masetti R:
Targeted therapies for pediatric AML: Gaps and perspective. Front
Pediatr. 7(463)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stuck MW, Chong WM, Liao JC and Pazour GJ:
Rab34 is necessary for early stages of intracellular ciliogenesis.
Curr Biol. 31:2887–2894.e4. 2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Xi Y, Shen W, Jin C, Wang L and Yu B: PVT1
promotes the proliferation and migration of non-small cell lung
cancer via regulating miR-148/RAB34 signal axis. Onco Targets Ther.
13:1819–1832. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wu J, Lu Y, Qin A, Qiao Z and Jiang X:
Overexpression of RAB34 correlates with poor prognosis and tumor
progression in hepatocellular carcinoma. Oncol Rep. 38:2967–2974.
2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sun L, Xu X, Chen Y, Zhou Y, Tan R, Qiu H,
Jin L, Zhang W, Fan R, Hong W and Wang T: Rab34 regulates adhesion,
migration, and invasion of breast cancer cells. Oncogene.
37:3698–3714. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Denechaud PD, Fajas L and Giralt A: E2F1,
a novel regulator of metabolism. Front Endocrinol (Lausanne).
8(311)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang K, Liu JD, Deng G, Ou ZY, Li SF, Xu
XL, Zhang MJ, Peng XQ and Chen FH: LncSIK1 enhanced the sensitivity
of AML cells to retinoic acid by the E2F1/autophagy pathway. Cell
Prolif. 55(e13185)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Feng Y, Hu S, Li L, Zhang S, Liu J, Xu X,
Zhang M, Du T, Du Y, Peng X and Chen F: LncRNA NR-104098 inhibits
AML proliferation and induces differentiation through repressing
EZH2 transcription by interacting with E2F1. Front Cell Dev Biol.
8(142)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Liu X, Cai Y, Cheng C, Gu Y, Hu X, Chen K,
Wu Y and Wu Z: PCLAF promotes neuroblastoma G1/S cell cycle
progression via the E2F1/PTTG1 axis. Cell Death Dis.
13(178)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li C, Tang Z, Zhang W, Ye Z and Liu F:
GEPIA2021: Integrating multiple deconvolution-based analysis into
GEPIA. Nucleic Acids Res. 49(W1):W242–W246. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hu H, Miao YR, Jia LH, Yu QY, Zhang Q and
Guo AY: AnimalTFDB 3.0: A comprehensive resource for annotation and
prediction of animal transcription factors. Nucleic Acids Res.
47(D1):D33–D38. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Livak KJ and Schmittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Costa-Pinheiro P, Montezuma D, Henrique R
and Jerónimo C: Diagnostic and prognostic epigenetic biomarkers in
cancer. Epigenomics. 7:1003–1015. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ganga AK, Kennedy MC, Oguchi ME, Gray S,
Oliver KE, Knight TA, De La Cruz EM, Homma Y, Fukuda M and Breslow
DK: Rab34 GTPase mediates ciliary membrane formation in the
intracellular ciliogenesis pathway. Curr Biol. 31:2895–2905.e7.
2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tzeng HT and Wang YC: Rab-mediated vesicle
trafficking in cancer. J Biomed Sci. 23(70)2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang HJ, Gao Y, Chen L, Li YL and Jiang
CL: RAB34 was a progression- and prognosis-associated biomarker in
gliomas. Tumour Biol. 36:1573–1578. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Luo H, Zhang H, Zhang Z, Zhang X, Ning B,
Guo J, Nie N, Liu B and Wu X: Down-regulated miR-9 and miR-433 in
human gastric carcinoma. J Exp Clin Cancer Res.
28(82)2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kent LN and Leone G: The broken cycle: E2F
dysfunction in cancer. Nat Rev Cancer. 19:326–338. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fouad S, Hauton D and D'Angiolella V:
E2F1: Cause and consequence of DNA replication stress. Front Mol
Biosci. 7(599332)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Malaney P, Palumbo E, Semidey-Hurtado J,
Hardee J, Stanford K, Kathiriya JJ, Patel D, Tian Z, Allen-Gipson D
and Davé V: PTEN Physically Interacts With And Regulates
E2F1-mediated transcription in lung cancer. Cell Cycle. 17:947–962.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rodriguez-Bravo V, Pippa R, Song WM,
Carceles-Cordon M, Dominguez-Andres A, Fujiwara N, Woo J, Koh AP,
Ertel A, Lokareddy RK, et al: Nuclear pores promote lethal prostate
cancer by increasing POM121-Driven E2F1, MYC, and AR nuclear
import. Cell. 174:1200–1215.e20. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ma J, He Z, Zhang H, Zhang W, Gao S and Ni
X: SEC61G promotes breast cancer development and metastasis via
modulating glycolysis and is transcriptionally regulated by E2F1.
Cell Death Dis. 12(550)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pulikkan JA, Dengler V, Peramangalam PS,
Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG and Behre G:
Cell-cycle regulator E2F1 and microRNA-223 comprise an
autoregulatory negative feedback loop in acute myeloid leukemia.
Blood. 115:1768–1778. 2010.PubMed/NCBI View Article : Google Scholar
|
